Nature5y
Reducing glutamate signaling pays off in fragile X
The study is also a genetic test of the 'mGluR theory' of FXS, which postulates that an important consequence of FXS is excessive signaling through group 1 metabotropic glutamate receptors (mGluRs ...
Medindia7d
FDA Grants Rare Pediatric Disease and Orphan Drug Designations to Nobias Therapeutics for Treatment of 22q11.2 Deletion Syndrome
Receiving Rare Pediatric Disease and Orphan Drug designations from the FDA are important mile markers in our efforts to develop the first therapeutic indicated for the neuropsychiatric ...